Oliver Neumann

Charité - Universitätsmedizin Berlin

Papers

2

Total Citations

63

H-Index

2

About

Oliver Neumann is a leading figure in the field of radiation oncology, with a focused expertise in the application of robotic radiosurgery for gynecologic malignancies, particularly cervical carcinoma. His major contribution lies in pioneering the use of CyberKnife® technology as a non-invasive alternative to traditional intracavitary brachytherapy. In his landmark 2013 study, cited 48 times, Neumann demonstrated that robotic radiosurgery could emulate the high-dose, conformal radiation profile of brachytherapy in patients with FIGO stage IIB-IIIB cervical cancer who were unsuitable for the standard procedure. This work provided critical dosimetric data and acute toxicity profiles, establishing a viable salvage or alternative treatment pathway. His subsequent 2014 paper further validated this approach, solidifying his role in expanding treatment options for a challenging patient population. Neumann’s research has directly influenced clinical protocols, offering a precise, image-guided solution that reduces procedural invasiveness while maintaining therapeutic efficacy. His work continues to be a cornerstone for researchers exploring stereotactic body radiation therapy (SBRT) in gynecologic oncology.

Research Focus

Key Achievements

2
H-Index
2
Papers
63
Total Citations
32
Avg Citations/Paper
🏆 Most Cited Paper
Brachytherapy-emulating robotic radiosurgery in patients with cervical carcinoma
48 citations · 2013
📈 Most Prolific Year: 2013 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Charité - Universitätsmedizin Berlin

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago